New Hampshire Clinical Trials

Recruiting studies in New Hampshire

• Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
  NCT06095583Limited-stage Small Cell Lung Cancer (LS-SCLC)Lebanon, NH
• Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
  NCT03606967Anatomic Stage IV Breast Cancer AJCC v8Lebanon, NH
• Radiation Therapy for Dupuytren's Contracture Following Non-Surgical Release
  NCT06330545Dupuytren ContractureLebanon, NH
• A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
  NCT06667076Carcinoma, Non-Small-Cell LungLebanon, NH
• Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
  NCT06172296Ganglioneuroblastoma, NodularLebanon, NH
• Restoration of Thumb Strength and Function in Basal Joint Arthritis: A Comparative Effectiveness Trial (RESTART)
  NCT04458584Osteoarthritis ThumbLebanon, NH
• A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
  NCT06890338Epithelial Ovarian CancerLebanon, NH
• Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
  NCT06677060Heart FailurePortsmouth, NH
• Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
  NCT07061964Muscle Invasive Bladder Urothelial CarcinomaLebanon, NH
• KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
  NCT04165798Carcinoma, Non-Small-Cell LungLebanon, NH
• Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
  NCT06317649Acute Myeloid LeukemiaLebanon, NH
• Pan Tumor Rollover Study
  NCT03899155CancerLebanon, NH

See all 271 recruiting New Hampshire trials →

Popular conditions in New Hampshire

• Breast Cancer
• Prostate Cancer
• Lung Cancer
• Colorectal Cancer
• Obesity
• Type 2 Diabetes
• Depression
• Alzheimer Disease
• Heart Failure
• Multiple Sclerosis
• Rheumatoid Arthritis
• Asthma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer
• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Frequently asked questions

How do I find clinical trials in New Hampshire?

Corterve aggregates actively recruiting clinical trials with sites in New Hampshire from the public ClinicalTrials.gov registry. Browse the studies on this page or take a free health assessment to find trials you may qualify for.

Are clinical trials in New Hampshire free to join?

Study participation is typically free — sponsors cover the investigational treatment and study-related visits, and many studies compensate participants for time and travel. Details vary by study.

What kinds of clinical trials are available in New Hampshire?

New Hampshire research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.